EPS for AngioDynamics, Inc. (ANGO) Expected At $0.17

September 8, 2018 - By Palma Niemeyer

AngioDynamics, Inc. (NASDAQ:ANGO) LogoInvestors sentiment increased to 1.46 in 2018 Q1. Its up 0.20, from 1.26 in 2017Q4. It is positive, as 17 investors sold AngioDynamics, Inc. shares while 40 reduced holdings. 25 funds opened positions while 58 raised stakes. 34.89 million shares or 2.93% more from 33.90 million shares in 2017Q4 were reported.
Moreover, Invesco has 0% invested in AngioDynamics, Inc. (NASDAQ:ANGO) for 230,516 shares. The New York-based Bank Of Mellon has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). Employees Retirement Of Texas accumulated 30,000 shares or 0.01% of the stock. Ubs Asset Americas, a Illinois-based fund reported 22,940 shares. Massachusetts-based Rhumbline Advisers has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). Segall Bryant & Hamill Ltd has 651,782 shares for 0.26% of their portfolio. Principal Fin Grp Inc Incorporated has invested 0% in AngioDynamics, Inc. (NASDAQ:ANGO). State Of New Jersey Common Pension Fund D holds 0% in AngioDynamics, Inc. (NASDAQ:ANGO) or 65,000 shares. Trexquant Inv Limited Partnership has invested 0.03% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Chicago Equity Prtn Ltd invested in 0.02% or 40,825 shares. First Quadrant L P Ca stated it has 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Teachers Retirement Of The State Of Kentucky holds 0% or 10,197 shares in its portfolio. Northern holds 1.20M shares. Geode Cap Mngmt Limited Liability Co stated it has 509,354 shares. Dimensional Fund Advsrs Lp reported 3.09M shares.

Analysts expect AngioDynamics, Inc. (NASDAQ:ANGO) to report $0.17 EPS on September, 27.They anticipate $0.05 EPS change or 41.67 % from last quarter’s $0.12 EPS. ANGO’s profit would be $6.30M giving it 34.84 P/E if the $0.17 EPS is correct. After having $0.20 EPS previously, AngioDynamics, Inc.’s analysts see -15.00 % EPS growth. The stock increased 0.13% or $0.03 during the last trading session, reaching $23.69. About 180,806 shares traded. AngioDynamics, Inc. (NASDAQ:ANGO) has risen 30.75% since September 8, 2017 and is uptrending. It has outperformed by 18.18% the S&P500.

AngioDynamics, Inc. (NASDAQ:ANGO) Ratings Coverage

Among 2 analysts covering Angiodynamics (NASDAQ:ANGO), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Angiodynamics had 3 analyst reports since March 29, 2018 according to SRatingsIntel. As per Thursday, March 29, the company rating was maintained by Canaccord Genuity. The firm earned “Hold” rating on Monday, April 2 by Canaccord Genuity. Raymond James upgraded AngioDynamics, Inc. (NASDAQ:ANGO) on Tuesday, April 3 to “Outperform” rating.

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company has market cap of $878.31 million. The firm provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It has a 53.84 P/E ratio. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support.

More news for AngioDynamics, Inc. (NASDAQ:ANGO) were recently published by: Nasdaq.com, which released: “Factors of Influence in 2018, Key Indicators and Opportunity within Okta, Great Lakes Dredge & Dock, MDC Partners …” on August 17, 2018. Seekingalpha.com‘s article titled: “AngioDynamics acquires sealant system using in lung biopsies” and published on August 15, 2018 is yet another important article.

AngioDynamics, Inc. (NASDAQ:ANGO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.